Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
17 févr. 2021 08h00 HE
|
Processa Pharmaceuticals, Inc.
Strengthened Financial Position Supports Execution Through 2023 HANOVER, MD., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a...